Jaime Elizabeth Medvene Phd A Professional Psychological Corpora | |
30200 Agoura Rd Suite 190 Agoura Hills CA 91301-5434 | |
(818) 981-7845 | |
Not Available |
Full Name | Jaime Elizabeth Medvene Phd A Professional Psychological Corpora |
---|---|
Speciality | Psychologist |
Location | 30200 Agoura Rd, Agoura Hills, California |
Authorized Official Name and Position | Jaime Elizabeth Medvene (PRESIDENT) |
Authorized Official Contact | 8189817845 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Jaime Elizabeth Medvene Phd A Professional Psychological Corpora 30200 Agoura Rd Suite 190 Agoura Hills CA 91301-5434 Ph: (818) 981-7845 | Jaime Elizabeth Medvene Phd A Professional Psychological Corpora 30200 Agoura Rd Suite 190 Agoura Hills CA 91301-5434 Ph: (818) 981-7845 |
NPI Number | 1306084272 |
---|---|
Provider Enumeration Date | 01/30/2009 |
Last Update Date | 05/15/2020 |
Certification Date | 05/15/2020 |
Medicare PECOS PAC ID | 7911063201 |
---|---|
Medicare Enrollment ID | O20090312000135 |
News Archive
Atox Bio Inc. today announced that it successfully completed the dosing of the first subject in its phase 1 clinical study of AB103, a novel therapy for the treatment of severe bacterial infections and sepsis.
Findings from a cost model suggest that expenses for systemic psoriasis therapy appear to be increasing at a faster rate than inflation, and newer biologically derived treatments are more expensive than traditional systemic therapies, according to a report in the January issue of Archives of Dermatology, one of the JAMA/Archives journals.
For years, researchers and physicians have known that infants' immune systems do not respond well to certain vaccines, thus the need for additional boosters as children develop.
New research from the University of Liverpool, published today in the journal 'NPJ Systems Biology and Applications', has identified 'cell messages' that could help identify the early stages of osteoarthritis.
› Verified 1 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1306084272 | NPI | - | NPPES |
PSY137401 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | CP13740 (California) | Primary |
Provider Name | Charles B Wasserman |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1659361731 PECOS PAC ID: 5698765485 Enrollment ID: I20040513001445 |
News Archive
Atox Bio Inc. today announced that it successfully completed the dosing of the first subject in its phase 1 clinical study of AB103, a novel therapy for the treatment of severe bacterial infections and sepsis.
Findings from a cost model suggest that expenses for systemic psoriasis therapy appear to be increasing at a faster rate than inflation, and newer biologically derived treatments are more expensive than traditional systemic therapies, according to a report in the January issue of Archives of Dermatology, one of the JAMA/Archives journals.
For years, researchers and physicians have known that infants' immune systems do not respond well to certain vaccines, thus the need for additional boosters as children develop.
New research from the University of Liverpool, published today in the journal 'NPJ Systems Biology and Applications', has identified 'cell messages' that could help identify the early stages of osteoarthritis.
› Verified 1 days ago
Provider Name | Luz E Vulgaris |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1215133020 PECOS PAC ID: 7618916628 Enrollment ID: I20050428001116 |
News Archive
Atox Bio Inc. today announced that it successfully completed the dosing of the first subject in its phase 1 clinical study of AB103, a novel therapy for the treatment of severe bacterial infections and sepsis.
Findings from a cost model suggest that expenses for systemic psoriasis therapy appear to be increasing at a faster rate than inflation, and newer biologically derived treatments are more expensive than traditional systemic therapies, according to a report in the January issue of Archives of Dermatology, one of the JAMA/Archives journals.
For years, researchers and physicians have known that infants' immune systems do not respond well to certain vaccines, thus the need for additional boosters as children develop.
New research from the University of Liverpool, published today in the journal 'NPJ Systems Biology and Applications', has identified 'cell messages' that could help identify the early stages of osteoarthritis.
› Verified 1 days ago
Provider Name | Jaime Elizabeth Medvene |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1265478754 PECOS PAC ID: 1759303134 Enrollment ID: I20051228000797 |
News Archive
Atox Bio Inc. today announced that it successfully completed the dosing of the first subject in its phase 1 clinical study of AB103, a novel therapy for the treatment of severe bacterial infections and sepsis.
Findings from a cost model suggest that expenses for systemic psoriasis therapy appear to be increasing at a faster rate than inflation, and newer biologically derived treatments are more expensive than traditional systemic therapies, according to a report in the January issue of Archives of Dermatology, one of the JAMA/Archives journals.
For years, researchers and physicians have known that infants' immune systems do not respond well to certain vaccines, thus the need for additional boosters as children develop.
New research from the University of Liverpool, published today in the journal 'NPJ Systems Biology and Applications', has identified 'cell messages' that could help identify the early stages of osteoarthritis.
› Verified 1 days ago
Provider Name | Deborah M Kenigsberg |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1487929857 PECOS PAC ID: 9830484591 Enrollment ID: I20160821000000 |
News Archive
Atox Bio Inc. today announced that it successfully completed the dosing of the first subject in its phase 1 clinical study of AB103, a novel therapy for the treatment of severe bacterial infections and sepsis.
Findings from a cost model suggest that expenses for systemic psoriasis therapy appear to be increasing at a faster rate than inflation, and newer biologically derived treatments are more expensive than traditional systemic therapies, according to a report in the January issue of Archives of Dermatology, one of the JAMA/Archives journals.
For years, researchers and physicians have known that infants' immune systems do not respond well to certain vaccines, thus the need for additional boosters as children develop.
New research from the University of Liverpool, published today in the journal 'NPJ Systems Biology and Applications', has identified 'cell messages' that could help identify the early stages of osteoarthritis.
› Verified 1 days ago
Provider Name | Tameeza Samji |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1578663613 PECOS PAC ID: 9739435538 Enrollment ID: I20180710001014 |
News Archive
Atox Bio Inc. today announced that it successfully completed the dosing of the first subject in its phase 1 clinical study of AB103, a novel therapy for the treatment of severe bacterial infections and sepsis.
Findings from a cost model suggest that expenses for systemic psoriasis therapy appear to be increasing at a faster rate than inflation, and newer biologically derived treatments are more expensive than traditional systemic therapies, according to a report in the January issue of Archives of Dermatology, one of the JAMA/Archives journals.
For years, researchers and physicians have known that infants' immune systems do not respond well to certain vaccines, thus the need for additional boosters as children develop.
New research from the University of Liverpool, published today in the journal 'NPJ Systems Biology and Applications', has identified 'cell messages' that could help identify the early stages of osteoarthritis.
› Verified 1 days ago
Provider Name | Christopher Gene Watson |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1982052635 PECOS PAC ID: 6507257565 Enrollment ID: I20211229002231 |
News Archive
Atox Bio Inc. today announced that it successfully completed the dosing of the first subject in its phase 1 clinical study of AB103, a novel therapy for the treatment of severe bacterial infections and sepsis.
Findings from a cost model suggest that expenses for systemic psoriasis therapy appear to be increasing at a faster rate than inflation, and newer biologically derived treatments are more expensive than traditional systemic therapies, according to a report in the January issue of Archives of Dermatology, one of the JAMA/Archives journals.
For years, researchers and physicians have known that infants' immune systems do not respond well to certain vaccines, thus the need for additional boosters as children develop.
New research from the University of Liverpool, published today in the journal 'NPJ Systems Biology and Applications', has identified 'cell messages' that could help identify the early stages of osteoarthritis.
› Verified 1 days ago
News Archive
Atox Bio Inc. today announced that it successfully completed the dosing of the first subject in its phase 1 clinical study of AB103, a novel therapy for the treatment of severe bacterial infections and sepsis.
Findings from a cost model suggest that expenses for systemic psoriasis therapy appear to be increasing at a faster rate than inflation, and newer biologically derived treatments are more expensive than traditional systemic therapies, according to a report in the January issue of Archives of Dermatology, one of the JAMA/Archives journals.
For years, researchers and physicians have known that infants' immune systems do not respond well to certain vaccines, thus the need for additional boosters as children develop.
New research from the University of Liverpool, published today in the journal 'NPJ Systems Biology and Applications', has identified 'cell messages' that could help identify the early stages of osteoarthritis.
› Verified 1 days ago
Brainlab Medical Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 27509 Agoura Rd Ste 205, Agoura Hills, CA 91301 Phone: 503-791-3205 | |
Todd L Perlmutter, Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 29395 Agoura Rd Ste 209, Agoura Hills, CA 91301 Phone: 818-597-0115 Fax: 818-889-5058 | |
Klc Consultants, Pc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 30101 Agoura Ct Ste 100, Agoura Hills, CA 91301 Phone: 818-879-9018 Fax: 818-879-9013 | |
Todd L. Perlmutter, Lcsw Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5737 Kanan Rd Ste 285, Agoura Hills, CA 91301 Phone: 818-597-0115 | |
Agoura Psychological Services, Inc. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 5014 Chesebro Rd, Second Floor, Agoura Hills, CA 91301 Phone: 888-691-3223 | |
Westlake Trauma Therapy Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 28720 Roadside Dr Ste 177, Agoura Hills, CA 91301 Phone: 805-358-9677 | |
Shannon Dobbs Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 28310 Roadside Dr Ste 203, Agoura Hills, CA 91301 Phone: 310-428-2431 Fax: 800-713-1290 |